Nature, Published online: 23 June 2026; doi:10.1038/d41586-026-01812-1
The scientific community awaits a patent for recombinant DNA technology, and experimentation with an anaesthetic from puffballs, in our weekly dip into Nature’s archive.
Trending
- US Appeals Court Blocks Trump’s $400m White House Ballroom Project – THISDAYLIVE
- How Access Bank is Nurturing Africa’s Next Generation of Innovators – THISDAYLIVE
- Gene-edited beagles may offer a future option for people with dog allergies | Gene editing
- Leeds extend lead at top of Super League after thrilling late win at Wakefield | Super League
- P-Square albums surge on Apple Music chart amid rift among Okoye brothers
- Vote Buying Worries INEC – THISDAYLIVE
- The Eternal War’ Taps A&M MoCap Lab For Previsualization
- Flesh-eating screwworms feast on humans in Mexico; human cases top 500
A 1970s patent that changed the course of commercial biotechnology
